Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Journey Medical (DERM) Return on Sales (2020 - 2026)

Journey Medical filings provide 6 years of Return on Sales readings, the most recent being 0.0% for Q4 2025.

  • On a quarterly basis, Return on Sales changed 0.0% to 0.0% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.0%, a 0.0% change, with the full-year FY2025 number at 0.0%, changed 0.0% from a year prior.
  • Return on Sales hit 0.0% in Q4 2025 for Journey Medical, up from 0.0% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.01% in Q3 2023 to a low of 0.01% in Q4 2021.
  • Median Return on Sales over the past 5 years was 0.0% (2025), compared with a mean of 0.0%.
  • Biggest five-year swings in Return on Sales: decreased -1bps in 2021 and later rose 2bps in 2023.
  • Journey Medical's Return on Sales stood at 0.01% in 2021, then skyrocketed by 36bps to 0.01% in 2022, then skyrocketed by 82bps to 0.0% in 2023, then surged by 189bps to 0.0% in 2024, then plummeted by -164bps to 0.0% in 2025.
  • The last three reported values for Return on Sales were 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025) per Business Quant data.